Diagnostic Test: simultaneous combined 18F-FDG PET and cardiac MRI imaging ( DrugBank: 18F-FDG )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 84 | Sarcoidosis | 1 |
84. Sarcoidosis
Clinical trials : 149 / Drugs : 227 - (DrugBank : 81) / Drug target genes : 82 - Drug target pathways : 167
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03356756 (ClinicalTrials.gov) | June 27, 2016 | 3/11/2017 | PET MRI Study in Patients With Cardiac Sarcoidosis | Diagnostic and Prognostic Significance of Combined PET/MRI in Inflammatory Cardiomyopathies and Sarcoidosis | Inflammatory Cardiomyopathy;Sarcoidosis | Diagnostic Test: simultaneous combined 18F-FDG PET and cardiac MRI imaging | University Health Network, Toronto | NULL | Recruiting | 18 Years | N/A | All | 60 | Canada |